Nucleome Therapeutics Limited
Nucleome Therapeutics is a biotechnology company focused on decoding the regulatory genome to develop precision medicines. Their technology platform aims to enhance the scale and precision of genetics-led drug discovery, particularly for complex diseases such as autoimmune disorders.
- Precision medicines
- Genetics-led drug discovery
- Biologics and small molecule approaches
Locations
Digital Popularity
Social Media
Competitors
Exscientia is a technology-driven company focused on AI drug discovery, aiming to revolutionise the pharmaceutical industry through precision medicine.
GeneOmics Solutions is dedicated to early diagnosis and treatment through the integration of multi-omics data for precision medicine.
Company Details
Nucleome Therapeutics Limited is operated by Nucleome Therapeutics Limited and is a Active company incorporated on 17 July 2019 with the registered office located in Oxford, Oxfordshire. Nucleome Therapeutics Limited was registered 6 years ago.
Status
Active
Size
Unreported
Directors
10
Age
6 years old
Employees
44
Turnover
£156K
Total Assets
£24.34M
Cash in Bank
£12.29M
Total Liabilities
-£1.31M
Teams
45
13
6
5
4
3
1
Vice President, Drug Discovery • Joined Jul 2024
Senior Vice President Operations • Joined Sep 2024
Senior Vice President, Data Science And Informatics • Joined Apr 2023
Chief Executive Officer • Joined Jul 2024
Executive Assistant To CEO And Board • Joined Apr 2024
Principal Scientist • Joined Feb 2023
Principal Scientist • Joined Oct 2023
Co-Founder And Consultant • Joined Aug 2019
Chief People Officer • Joined Jan 2025
Principal Computational Biologist • Joined Mar 2024
Principal Scientist • Joined Feb 2023
Principal Scientist • Joined Oct 2023
Research Assistant • Joined Oct 2022
Scientist • Joined Feb 2022
Scientist • Joined Jan 2025
Computational Biologist • Joined Feb 2025
Bioinformatician • Joined Sep 2022
Senior Bioinformatician • Joined Jun 2023
Senior Scientist • Joined Jan 2024
Senior Scientist • Joined Apr 2024
Chief Executive Officer • Joined Jul 2024
Co-Founder And Consultant • Joined Aug 2019
Chief People Officer • Joined Jan 2025
Information Technology Lead • Joined Jul 2022
Laboratory Manager • Joined Apr 2023
Team Leader & Director - Drug Discovery • Joined Aug 2024
Chief People Officer • Joined Jan 2025
HR Business Partner • Joined Jan 2025
Talent Manager • Joined Mar 2021
Co-Founder And Consultant • Joined Aug 2019
Chief People Officer • Joined Jan 2025
Team Leader & Director - Drug Discovery • Joined Aug 2024
Board Member • Joined Oct 2022
Scientific Advisory Board • Joined May 2024
Chief Executive Officer • Joined Jul 2024
Executive Assistant To CEO And Board • Joined Apr 2024
Board Member • Joined Oct 2022
Board Observer • Joined Mar 2023
Finance Assistant • Joined Mar 2024
View 45 members